A new, AI-based service VEIL.AI enables patient data anonymisation better and faster than traditional methods. At the same time it maintains the level of statistical data significant for research purposes.
Developed by the Institute for Molecular Medicine Finland (FIMM), the application is now available for the ELIXIR infrastructure, alongside which a joint service is now being developed. An organisation managing data can protect it by entering the related metadata into a scalable cloud service. The service disguises any identity attributes, providing researchers with anonymised and, if necessary, synthetic data.
ELIXIR is partly funded by the European Commission